vs

Side-by-side financial comparison of CME Group (CME) and CSX Corporation (CSX). Click either name above to swap in a different company.

CSX Corporation is the larger business by last-quarter revenue ($3.5B vs $1.9B, roughly 1.9× CME Group). CSX Corporation runs the higher net margin — 23.2% vs 0.1%, a 23.1% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 1.7%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -3.0%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

CSX Transportation, known colloquially as simply CSX, is a Class I freight railroad company operating in the Eastern United States and the Canadian provinces of Ontario and Quebec. Operating about 21,000 route miles (34,000 km) of track, it is the leading subsidiary of CSX Corporation, a Fortune 500 company headquartered in Jacksonville, Florida.

CME vs CSX — Head-to-Head

Bigger by revenue
CSX
CSX
1.9× larger
CSX
$3.5B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+12.8% gap
CME
14.5%
1.7%
CSX
Higher net margin
CSX
CSX
23.1% more per $
CSX
23.2%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-3.0%
CSX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
CSX
CSX
Revenue
$1.9B
$3.5B
Net Profit
$1.2M
$807.0M
Gross Margin
Operating Margin
0.1%
29.9%
Net Margin
0.1%
23.2%
Revenue YoY
14.5%
1.7%
Net Profit YoY
20.7%
401.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
CSX
CSX
Q1 26
$1.9B
$3.5B
Q4 25
$1.6B
$3.5B
Q3 25
$1.5B
$3.6B
Q2 25
$1.7B
$3.6B
Q1 25
$1.6B
$3.4B
Q4 24
$1.5B
$3.5B
Q3 24
$1.6B
$3.6B
Q2 24
$1.5B
$3.7B
Net Profit
CME
CME
CSX
CSX
Q1 26
$1.2M
$807.0M
Q4 25
$1.2B
$720.0M
Q3 25
$908.0M
$694.0M
Q2 25
$1.0B
$829.0M
Q1 25
$956.2M
$646.0M
Q4 24
$874.6M
$720.0M
Q3 24
$912.8M
$894.0M
Q2 24
$883.2M
$963.0M
Operating Margin
CME
CME
CSX
CSX
Q1 26
0.1%
29.9%
Q4 25
61.8%
31.6%
Q3 25
63.3%
30.3%
Q2 25
66.7%
35.9%
Q1 25
67.5%
30.4%
Q4 24
62.1%
30.8%
Q3 24
64.6%
37.4%
Q2 24
65.3%
39.1%
Net Margin
CME
CME
CSX
CSX
Q1 26
0.1%
23.2%
Q4 25
71.7%
20.5%
Q3 25
59.1%
19.3%
Q2 25
60.6%
23.2%
Q1 25
58.2%
18.9%
Q4 24
57.3%
20.3%
Q3 24
57.6%
24.7%
Q2 24
57.6%
26.0%
EPS (diluted)
CME
CME
CSX
CSX
Q1 26
Q4 25
$3.24
$0.39
Q3 25
$2.49
$0.37
Q2 25
$2.81
$0.44
Q1 25
$2.62
$0.34
Q4 24
$2.40
$0.38
Q3 24
$2.50
$0.46
Q2 24
$2.42
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
CSX
CSX
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.1B
Total DebtLower is stronger
$3.4B
$18.9B
Stockholders' EquityBook value
$13.6B
Total Assets
$202.0B
$44.2B
Debt / EquityLower = less leverage
1.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
CSX
CSX
Q1 26
$2.4B
$1.1B
Q4 25
$4.5B
$5.0M
Q3 25
$2.6B
$6.0M
Q2 25
$2.1B
$6.0M
Q1 25
$1.5B
$8.0M
Q4 24
$3.0B
$72.0M
Q3 24
$2.4B
$12.0M
Q2 24
$1.9B
$4.0M
Total Debt
CME
CME
CSX
CSX
Q1 26
$3.4B
$18.9B
Q4 25
$18.2B
Q3 25
$18.6B
Q2 25
$18.6B
Q1 25
$18.5B
Q4 24
$17.9B
Q3 24
$18.5B
Q2 24
$18.0B
Stockholders' Equity
CME
CME
CSX
CSX
Q1 26
$13.6B
Q4 25
$28.7B
$13.2B
Q3 25
$28.2B
$12.8B
Q2 25
$27.7B
$12.4B
Q1 25
$27.0B
$12.2B
Q4 24
$26.5B
$12.5B
Q3 24
$28.2B
$12.9B
Q2 24
$27.6B
$12.6B
Total Assets
CME
CME
CSX
CSX
Q1 26
$202.0B
$44.2B
Q4 25
$198.4B
$43.7B
Q3 25
$187.1B
$43.3B
Q2 25
$179.9B
$42.9B
Q1 25
$157.8B
$43.2B
Q4 24
$137.4B
$42.8B
Q3 24
$137.8B
$43.1B
Q2 24
$123.4B
$42.4B
Debt / Equity
CME
CME
CSX
CSX
Q1 26
1.39×
Q4 25
1.38×
Q3 25
1.45×
Q2 25
1.50×
Q1 25
1.52×
Q4 24
1.43×
Q3 24
1.43×
Q2 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
CSX
CSX
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$793.0M
FCF MarginFCF / Revenue
22.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters
$2.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
CSX
CSX
Q1 26
$1.3B
Q4 25
$1.1B
$1.4B
Q3 25
$968.1M
$1.3B
Q2 25
$1.1B
$635.0M
Q1 25
$1.1B
$1.3B
Q4 24
$1.0B
$1.4B
Q3 24
$1.0B
$1.7B
Q2 24
$776.9M
$1.1B
Free Cash Flow
CME
CME
CSX
CSX
Q1 26
$793.0M
Q4 25
$1.1B
$709.0M
Q3 25
$949.7M
$607.0M
Q2 25
$1.0B
$-141.0M
Q1 25
$1.1B
$536.0M
Q4 24
$991.7M
$550.0M
Q3 24
$973.2M
$1.1B
Q2 24
$758.7M
$547.0M
FCF Margin
CME
CME
CSX
CSX
Q1 26
22.8%
Q4 25
66.8%
20.2%
Q3 25
61.8%
16.9%
Q2 25
61.5%
-3.9%
Q1 25
67.1%
15.7%
Q4 24
65.0%
15.5%
Q3 24
61.4%
29.3%
Q2 24
49.5%
14.8%
Capex Intensity
CME
CME
CSX
CSX
Q1 26
Q4 25
2.0%
19.3%
Q3 25
1.2%
20.4%
Q2 25
1.1%
21.7%
Q1 25
0.9%
21.0%
Q4 24
1.7%
23.7%
Q3 24
1.9%
17.3%
Q2 24
1.2%
14.6%
Cash Conversion
CME
CME
CSX
CSX
Q1 26
1.58×
Q4 25
0.96×
1.93×
Q3 25
1.07×
1.93×
Q2 25
1.03×
0.77×
Q1 25
1.17×
1.94×
Q4 24
1.16×
1.93×
Q3 24
1.10×
1.89×
Q2 24
0.88×
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons